Publications by authors named "R H Carnahan"

Article Synopsis
  • The N-terminal domain (NTD) of the spike protein in coronaviruses like SARS-CoV-2 is not well understood, but some rare antibodies targeting it can neutralize the virus, indicating its potential role in immune protection.
  • A specific monoclonal antibody, COV1-65, has been identified that effectively recognizes the NTD of the SARS-CoV spike protein and demonstrated disease prevention in mice when administered before viral exposure.
  • The interaction between COV1-65 and the SARS-CoV spike protein reveals key structural details that could inform the development of effective vaccines against various sarbecoviruses.
View Article and Find Full Text PDF

Patients with opioid use disorder (OUD) represent a high-risk population due to increased rates of adverse health outcomes and death. To evaluate whether telehealth utilization during OUD treatment compared with in-person encounters alone was associated with emergency department (ED) utilization, inpatient admissions, and mortality within three years of initiating buprenorphine. We conducted a retrospective cohort study within the Veterans Health Administration among Veterans treated for OUD between 2012 and -2022.

View Article and Find Full Text PDF

Objective: We evaluate change in low back pain (LBP) intensity and interference as the mechanism by which chiropractic care affects other biopsychosocial factors in US active-duty military members.

Design: We conducted secondary, exploratory mediation analysis of pragmatic, multisite, clinical trial (NCT01692275) post results using natural effect modeling. Mediators were the 6-week values of Patient-Reported Outcomes Measurement Information System (PROMIS)-29 pain interference and intensity.

View Article and Find Full Text PDF

Human respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) are frequent drivers of morbidity and mortality in susceptible populations, most often infantile, older adults, and immunocompromised. The primary target of neutralizing antibodies is the fusion (F) glycoprotein on the surface of the RSV and hMPV virion. As a result of the structural conservation between RSV and hMPV F, three antigenic regions are known to induce cross-neutralizing responses: sites III, IV, and V.

View Article and Find Full Text PDF